Attention-Deficit Hyperactivity Disorder Treatment Market is projected to Reach USD 15.4 Billion, Garnering A 3.1% CAGR from 2024 to 2034

The increased awareness of ADHD and the considerable research and development efforts in this area are driving the expansion of the global market for ADHD treatments.

Wilmington, Delaware, United States, Transparency Market Research Inc.-, Aug. 12, 2024 (GLOBE NEWSWIRE) — The attention-deficit hyperactivity disorder treatment market (주의력 결핍 과잉 행동 장애 치료 시장) was projected to attain US$ 11 billion in 2023. It is likely to garner a 3.1% CAGR from 2024 to 2034, and by 2034, the market is expected to attain US$ 15.4 billion.

A frequent neurodevelopmental problem in children is Attention-Deficit Hyperactivity problem (ADHD). Children with ADHD are more likely to struggle with paying attention, managing impulsive actions, or overreacting.

Other signs of ADHD include daydreaming, sloppy blunders or reckless actions, difficulty avoiding temptation, and trouble forming positive relationships with others.

Download Sample PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86064

In addition to heredity, additional potential causes of ADHD include brain damage, early life exposure to environmental hazards, exposure to alcohol or smoke during pregnancy, preterm delivery, and low birth weight.

Key Findings of Market Report

• Children and Adults with ADD (CHADD) and other organizations hold awareness campaigns, educational seminars, and activities during October each year to raise awareness of ADHD.
• The 2021 Awareness Month campaign invited people to share their experiences overcoming ADHD by using the hashtag #ADHDperspectives2021. The biggest benefit is that scientific education and public health initiatives aim to debunk misconceptions about ADHD, which promotes diagnosis as well as treatment.
• For example, the CDC releases guidelines emphasizing the need of medicine and behavioral therapies. Additionally, it emphasizes the American Academy of Pediatrics recommendations, which state that behavioral techniques should be the primary line of treatment for children between the ages of four and six.
• Thus, periodic awareness initiatives on ADHD are defining the market’s potential for growth in ADHD treatments.

Market Trends For Attention-Deficit Hyperactivity Disorder Treatment

• Governments, non-governmental organizations, and medical institutions are placing a strong emphasis on the discovery of new therapies for ADHD.
• For example, according to a study published in NeuroImage Clinical in May 2020 titled “Neurofunctional and Behavioral Measures Associated with fMRI-Neurofeedback Learning in Adolescents with Attention-Deficit Hyperactivity Disorder,” the Medical Research Council provided US$ 1.6 million to fund a larger trial involving 100 ADHD children.
• Collaborations with Dresden University and the National Institute of Mental Health were also made possible by this financing.
• In order to test additional non-invasive brain stimulation treatments for ADHD, such as transcranial direct stimulation and stimulation of the trigeminal nerve, they were also awarded US$ 2.5 million by the National Institute of Health Research’s Action Medical Research.

Global Market for Attention-Deficit Hyperactivity Disorder Treatment: Regional Outlook

Various reasons propel the attention-deficit hyperactivity disorder treatment market growth throughout the regions. These are:

• To improve their position, businesses in the market for treatments for attention deficit hyperactivity disorder use inorganic methods of growth.
• According to the most recent research of the market for treatments for attention deficit hyperactivity disorder, North America was the leader in the field of ADHD therapy in 2023, and this trend is anticipated to continue during the forecast period.
• This is explained by the rising incidence of ADHD in this area. According to the Center for ADHD Awareness Canada (CADDAC), there are more than 1.5 million Canadians who suffer with ADHD.
• The identification of Asia Pacific as a high-speed ADHD area has contributed to the growth of the attention-deficit hyperactivity disorder treatment market in that region. A National Center for Biotechnology Information research states that around 7% of Chinese children and teens have ADHD.

Unlock Growth Potential in Your Industry! Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86064

Attention-Deficit Hyperactivity Disorder Treatment Market (سوق علاج اضطراب نقص الانتباه وفرط النشاط): Key Players

To improve their position, businesses in the market for treatments for attention deficit hyperactivity disorder use inorganic methods of growth.

An example of this is the collaboration agreement that Siemens Healthcare GmbH and HMI Group signed in February 2022 to promote the establishment of centers of excellence to improve diagnosis, treatment, and care across Southeast Asia.

The following companies are well-known participants in the attention-deficit hyperactivity disorder treatment market:

• Eli Lilly and Company
• Pfizer Inc.
• Johnson & Johnson
• Lupin Limited
• Novartis AG
• The Takeda Pharmaceutical Company Limited
• Mallinckrodt Pharmaceuticals
• Purdue Pharma L.P.
• Neos Therapeutics Inc.
• Supernus Pharmaceutical, Inc.
• Others

Key Developments

• KemPharma stated in July 2021 that it has introduced AZSTRAYS, a once-daily pill intended to treat people with ADHD.
• Tris Pharma, Inc. and Neuraxpharm Group signed a contract in December 2020 to market and sell Quillivant XR & Quillichew ER, two of Tris’ ADHD treatment products, in Europe.

Global Attention-Deficit Hyperactivity Disorder Treatment Market Segmentation 

• Drug Type
  • Others Stimulants
  • Non-stimulants
• Age
  • Children (2 to 17 years of age)
  • Adults
• Distribution Channel
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
• By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Purchase the Report for Market-Driven Insights:
https://www.transparencymarketresearch.com/checkout.php?rep_id=86064&ltype=S
Have a Look at More Valuable Insights of Pharmaceutical

Consumer Genomics Market (消費者ゲノミクス市場): The global consumer genomics market was estimated to have acquired US$ 2.4 billion in 2021. It is anticipated to register a 22.3% CAGR from 2022 to 2032 and by 2032, the market is likely to gain US$ 21.2 billion.

Dental Anesthetics Market (Marché des anesthésiques dentaires): The global dental anesthetics market is likely to expand at a CAGR of 2.6% from 2022 to 2031. Dental anesthesia is used to relieve pain in the mouth caused by sores, toothache, fever blisters, canker sores, and cold sores. Usage of dental anesthesia is considered a safe procedure.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com    
Email: [email protected]

Follow Us: LinkedIn| Twitter| Blog | YouTube